Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada. Show more
2150 St. Elzéar Blvd. West, Laval, QC, H7L 4A8, Canada
Market Cap
2.103B
52 Wk Range
$4.41 - $8.69
Previous Close
$5.54
Open
$5.62
Volume
1,335,657
Day Range
$5.49 - $5.63
Enterprise Value
21.64B
Cash
1.309B
Avg Qtr Burn
N/A
Insider Ownership
30.41%
Institutional Own.
65.74%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
